Idexx Laboratories Inc
IDXXNasdaqCIK 874716HealthcareFiscal year ends Dec 31
Reports and events: 245 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0416:16 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0000874716-26-000123 |
| 2026-08-0406:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-090033 |
| 2026-05-1516:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000874716-26-000110 |
| 2026-05-0516:14 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000874716-26-000076 |
| 2026-05-0506:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-055203 |
| 2026-03-2716:00 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0000874716-26-000064 |
| 2026-03-2608:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-034906 |
| 2026-02-2016:09 ET | 10-K | Annual reportPeriod 2025-12-31 | 0000874716-26-000038 |
| 2026-02-1317:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000874716-26-000007 |
| 2026-02-0206:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-008904 |
| 2026-01-1308:33 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-003103 |
| 2025-11-1316:07 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-25-111278 |
| 2025-11-0316:13 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000874716-25-000165 |
| 2025-11-0306:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-105185 |
| 2025-10-0707:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-097319 |
| 2025-08-0416:22 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000874716-25-000121 |
| 2025-08-0406:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-073304 |
| 2025-07-1007:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-066840 |
| 2025-05-0916:00 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000874716-25-000085 |
| 2025-05-0116:11 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000874716-25-000062 |
| 2025-05-0106:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-042955 |
| 2025-03-2816:00 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0000874716-25-000054 |
| 2025-02-2108:28 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000874716-25-000037 |
| 2025-02-1416:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000874716-25-000011 |
| 2025-02-0306:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-008331 |
| 2024-12-1216:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000874716-24-000150 |
| 2024-12-0907:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000874716-24-000148 |
| 2024-11-2107:32 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-121326 |
| 2024-11-1207:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-116365 |
| 2024-11-0616:00 ET | 8-K | 1.01 Entry into a material agreement | 0000874716-24-000142 |
| 2024-10-3116:14 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000874716-24-000139 |
| 2024-10-3113:23 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-112975 |
| 2024-10-3106:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-112826 |
| 2024-08-0616:07 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000874716-24-000121 |
| 2024-08-0606:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-086074 |
| 2024-05-1016:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000874716-24-000107 |
| 2024-05-0116:13 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000874716-24-000083 |
| 2024-05-0106:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-055201 |
| 2024-03-2716:00 ET | DEF 14A | Proxy statementPeriod 2023-12-31 | 0000874716-24-000075 |
| 2024-02-2216:17 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000874716-24-000057 |
| 2024-02-0506:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-24-000165 |
| 2023-12-0716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000874716-23-000143 |
| 2023-11-0116:20 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000874716-23-000128 |
| 2023-11-0106:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-23-001588 |
| 2023-08-0116:08 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000874716-23-000100 |
| 2023-08-0106:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-23-001198 |
| 2023-07-1207:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000874716-23-000092 |
| 2023-05-1916:00 ET | 8-K | 5.07 Shareholder vote results | 0000874716-23-000074 |
| 2023-05-0216:02 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000874716-23-000034 |
| 2023-05-0206:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001157523-23-000670 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:55 ET. Listed shows no prices and gives no investment advice.